baber/WOPTO huggingface dataset:
Patent MD-20060232-A (MD)
Title: Sun-light collector (variants)
Inventor: DRĂGUŢANU Serghei
IPC: F24S23/70
Filed: 2006-09-20
Abstract: The invention relates to the solar engineering, in particular to the solar collectors converting the sun electromagnetic radiation into heat energy, and can be used in the systems for hot-water supply and for heating of living and industrial structures.The sun-light collector, according to the first variant, comprises an absorber (1) with parallel channels (2) for passage of heated liquid. The absorber (1), equipped with branch pipes (3) and (4) for admission and withdrawal of heated liquid, is covered on the outside with an absorber layer (5), and on the backside - with a reflecting one (6), the parallel channels (2) of the absorber (1) being separated by partitions (7), the end faces of which are displaced from the walls (8) and (9) forming a labyrinth.The sun-light collector, according to the second variant, comprises an absorber with parallel channels for passage of heated liquid, separated by partitions, the cavities of which are joined on the end faces with hydraulic collectors, wherein there are mounted branch pipes for admission and withdrawal of heated liquid.The result of the invention consists in reducing the heat loss and in increasing the absorption capacity.
Patent NZ-194376-A (NZ)
Title: 1-aryl-2-(1,2,4-triazol-1-yl)-alkenes and fungicidal compositions
Inventor: BUECHEL K
IPC: C07D249/08
Filed: 1980-07-18
Abstract: A triazolyl-alkene of the formula   <IMAGE>   in which R is an alkyl radical or an optionally substituted phenyl radical, R1 is a cycloalkyl radical, and R2 is a hydrogen atom, or R1 and R2 together, in the o-position relative to each other, are an optionally substituted polymethylene bridge, or, together with the phenyl ring, are naphthyl, R3 is a halogen atom or an alkyl, alkoxy or halogenoalkyl radical, n is 0, 1, 2 or 3, and X is a keto radical or a -CH(OH)-radical, or an acid addition salt or metal salt complex thereof, which possesses fungicidal activity.
Patent NZ-204530-A (NZ)
Title: A metronidazole ester
Inventor: THORBEK P
IPC: C07D233/95
Filed: 1983-06-10
Abstract: Novel N,N-dimethylglycine ester of metronidazole, acid addition salt thereof and method of preparing such ester or acid addition salt. The novel compounds exhibit favourable solubility in water and are especially useful for the parenteral treatment of certain anaerobic infections.
Patent NZ-215446-A (NZ)
Title: Soft cheese manufacture
Inventor: SOZZI T
IPC: A23C19/032
Filed: 1986-03-11
Abstract: A soft, unripened cheese having a dry matter content of from 18 to 35%, of which at least 40% consists of the non-fat solids of milk. The cheese is prepared from concentrated milk by innoculating the milk with a culture of a combination of strains of thickening Streptococcus cremoris, strongly acidifying Streptococcus cremoris and mildly acidifying Streptococcus lactis.
Patent NZ-242775-A (NZ)
Title: Substituted imidazo [1,2-a](pyrrolo, thieno or furano)[3,2-d]azepine derivatives, preparation and pharmaceutical compositions
Inventor: JANSSENS FRANS EDUARD
IPC: C07D491/147
Filed: 1992-05-15
Abstract: The present invention is concerned with novel imidazo[1,2-a](pyrrolo, thieno or furano)[3,2-d]azepines of formula <CHEM> the pharmaceutically acceptable addition salts and stereochemically isomeric forms thereof, wherein each of the dotted lines independently represents an optional bond;     R<1>   represents hydrogen, C1-4alkyl, halo, ethenyl substituted with hydroxycarbanyl or C1-4alkyloxycarbonyl, hydroxyC1-4alkyl, formyl, hydroxycarbonyl or hydroxycarbonylC1-4alkyl; R<2>   represents hydrogen, C1-4alkyl, ethenyl substituted with hydroxycarbonyl or C1-4alkyloxycarbonyl, C1-4alkyl substituted with hydroxycarbonyl or C1-4alkyloxycarbonyl, hydroxyC1-4alkyl, formyl or hydroxycarbonyl; R<3>   represents hydrogen, C1-4alkyl, hydroxyC1-4alkyl, phenyl or halo; L   represents hydrogen; C1-6alkyl; C1-6alkyl substituted with one substituent selected from the group consisting of hydroxy, halo, C1-4alkyloxy, hydroxycarbonyl, C1-4alkyloxycarbonyl, C1-4alkyloxycarbonylC1-4alkyloxy, hydroxycarbonylC1-4alkyloxy, C1-4alkyloxycarbonylamino, C1-4alkylaminocarbonyl, C1-4alkylaminocarbonylamino, C1-4alkylaminothiocarbonylamino, aryl, aryloxy and arylcarbonyl; C1-6alkyl substituted with both hydroxy and aryloxy; C3-6alkenyl; C3-6alkenyl substituted with aryl; L represents a radical of formula -Alk-Y-Het<1> (a-1), -Alk-NH-CO-Het<2> (a-2) or -Alk-Het<3> (a-3); which are useful antiallergic compounds. Compositions comprising said compounds, methods of using, and processes for preparing the same.
Patent NZ-265599-A (NZ)
Title: Quinoxalindione derivatives, preparation and pharmaceutical compositions thereof
Inventor: HUTH ANDREAS
IPC: C07F9/6509
Filed: 1994-04-28
Abstract: Quinoxalinedione derivs. of formula (I) and their isomers and salts, are new. R<1> = (CH2)nCR<2>H(CH2)m-Z; R<5>-R<8> = H, T, CF3, NO2, halo, NR<9>R<10>, CN, SOPR<11>, SO2NR<12>R<13>, SO3H, SO3T or OR<14>; T = 1-6C alkyl; R<2> = H or (CH2)qR<3>; R<3> = H, OH, OT or NR<15>R<16>; r,m,q = 0, 1, 2 or 3; Z = POXY, OPOXY, OR<17>, NR<18>R<19>, NHCOR<20>, NHSO2R<21>, SO2R<22>, CO2R<23>, halo, CN or tetrazolyl; R<11> = H, T or phenyl; p = 0, 1 or 2; R<12>, R<13>, R<17>, R<23> = H or Q; Q = 1-4C alkyl; R<14> = H, or Q; Q = 1-4C alkyl; R<14> = H, or Q (opt. substd. by 1-3 halo); R<20>, R<21> = T, phenyl (opt. substd. by halo), or heteroaryl; R<22> = HO, TO or NR<24>R<25>; X,Y = OH, TO, Q or NR<18>R<19>; R<9>,R<10> = H, COT, phenyl, or T (opt. substd. by QO, NH2, NHQ or N(Q)2); or NR<9>R<10> = a 5-7 membered satd. heterocycle (which contains one other N, O or S atom and which is opt. substd.), or an unsatd. 5-membered heterocycle (which contains 1-3N atoms and which is opt. substd.); R<15>, R<16>,R<18>,R<19> = H, Q or phenyl; or NR<15>R<16> and/or NR<18>R<19> = a gp. as NR<9>R<10>; R<24>, R<25> = H or Q; or NR<24>R<25> = a satd. 5-7 membered heterocycle (which contains one other S, O or N atom and which is opt. substd.). Provided that (a) when R<2> is H and Z is CO2R<23> or POXY, then R<5>-R<8> are not H; (b) when R<2> is H, Z is POXY or CO2R<23> and R<5>, R<6>, R<7> or R<8> is CF3, NO2, NH2, halo or Me, the cpds. (I) are disubstituted.; (c) when R<1> is methanephosphonic acid and R<6> is CN or substd. imidazolyl, then R<5>, R<7> and R<8> cannot all be H; (d) when R<1> is methanephosphonic acid, R<6> is CF3 or NO2 and R<7> is imidazolyl, then R<5> and R<8> cannot both be H; and (e) when R<1> is CH2COOH and R<5> and R<8> are H, then R<6> and R<7> cannot both be halo or Me.
Patent NZ-312047-A (NZ)
Title: Pergola support comprising attachment portions (wall plate bracket and rafter bracket) and connection means (threaded bolt))
Inventor: DUNKINSON DON
IPC: E04D1/30
Filed: 1996-07-12
Abstract: A structural member 25, for supporting an appendant structure, e.g. a pergola 27, from a roofing structure 10 having beams 12 and cladding 16, includes a first attachment portion 30, for attachment to one of the beams, a second attachment portion 38, for supporting appendant structure 27 and a connecting means extending between attachment portions 30, 38.  The connecting means includes at least two elongate detachable parts 34, 36, both of which have smaller dimensions than portions 30, 38.  The connecting means is adapted to extend through the roof cladding 16.  Member 25 may include a sealing means, e.g. rubber tube 50 which extends around one of the elongate detachable parts, e.g. threaded rod 34 or tube portion 36, of the connecting means to provide a seal between the part and the roof cladding.
Patent NZ-321293-A (NZ)
Title: Sulfonamide inhibitors of matrix metalloproteinases
Inventor: WHITE ANDREW DAVID
IPC: C07D211/14
Filed: 1996-10-18
Abstract: The compounds of formula I are inhibitors of matrix metalloproteinases, particularly stromelysin-1 and gelatinase A (72 kD gelatinase).  The compounds may be used in medicaments to treat multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, burns, decubital ulcers, chronic ulcers or wounds, cancer metastasis, tumour angiogenesis, arthritis, or other autoimmune or inflammatory disorders dependent upon tissue invasion by leukocytes. In formula I: Ar is selected from phenyl or phenyl substituted with alkyl, NO2, halogen, OR5, CN, CO2R5, SO3R5, CHO, COR5, CONHR5, NHR5 or NHCOR5; R1 is hydrogen, methyl, NO2, Cl, NH2, NHCO2CH3, OH or CO2H; R2, R3 and Ra are the same or different and are independently selected from hydrogen, alkyl, (CH2)v-phenyl, (CH2)v-indolyl, (CH2)v-cycloalkyl, (CH2)tNR6R6a, (CH2)vR7, (CH2)vCO2R5, (CH2)vCONR6R6a or (CH2)vSR5; m is zero or 1; Y is CH; z is zero or 1; W is CHR8; n is zero or 1; R4 is OH, NR6R6a or NHOR9; R5 is hydrogen or alkyl; v is 1 to 5; X is O or S; p and q are independently 1 to 5, provided that p+q is not greater than 5; t is 1 to 9; R6 and R6a are each the same or different and are hydrogen or alkyl; R7 is 1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl, or 1,3-dihydro-1,3-dioxo-benzo[f]isoindol-2-yl; R8 is hydrogen or alkyl; and R9 is hydrogen, alkyl, or benzyl.
Patent NZ-324737-A (NZ)
Title: A step wise process for treating an aqueous starting phase (PAD) solution of titanyle sulfate resulting from etching of titanium containing ores by sulfuric acid
Inventor: CORDELET FREDERIC
IPC: C01G23/053
Filed: 1996-12-20
Abstract: A treatment process starting with an aqueous phase (PAD) containing titanium and sulfuric acid produced by the attack of sulfuric acid on titaniferous ores of the type in which the following steps are used:  1. An extraction step in which the starting aqueous phase is placed in contact with an organic extraction phase (POE) containing one or a plurality of organo-phosphorus compounds, by means of which an organic phase containing titanium and sulfuric acid is obtained;  2. Then, a regeneration step in which the organic phase containing titanium and sulfuric acid (PO) is regenerated by contact with an aqueous phase (PARf) containing titanium is obtained;  Characterised in that, it includes an additional step in which all or part of the regenerated aqueous phase (PARf) is placed in contact with an organic washing phase (POL), by means of which a treated aqueous phase (PAT) containing titanium is obtained.
Patent NZ-330389-A (NZ)
Title: Containers for storing one or more lipid components that are to be admixed together to create a final solution for medical purposes, the interior of the container has at least two components separated by a peelable seal
Inventor: BECKER MICHAEL
IPC: A61J1/05
Filed: 1997-09-09
Abstract: Containers for storing medical solutions are provided. More specifically, containers for storing components that are to be admixed together to create a final solution, one of the components comprising a lipid. In an embodiment, a container including an interior defining at least two chambers. The first chamber includes a lipid-containing liquid. The second chamber includes a liquid that does not include a lipid. A peelable seal separates the first and second chambers.  The container is constructed of a plastic film including a first layer contacting the liquid and a second layer outside the first.  The first layer includes a composition of two materials having separate melt points.
Patent NZ-331282-A (NZ)
Title: Tamper evident container/lid, the container having an inner and outer rim, the outer rim including at least one frangible member
Inventor: GALANTAI RODERICK FRANCIS
IPC: B65D50/14
Filed: 1998-08-06
Abstract: A tamper evident lidded container assembly.
Patent NZ-334209-A (NZ)
Title: Water repellent for automobile window glass comprising alkylpolysiloxane, acidity adjusting agent, and a solvent
Inventor: USHIJIMA TAKASHI
IPC: C03C17/30
Filed: 1998-06-22
Abstract: A water repellant for automobile window glass comprising alkyl polysiloxane, an acidity adjusting agent, a water type solvent, and at least one of six components represented by the following general formula 1, 2, and 3 where X1, X2, and X3 are a long chain alkyl group having 16-50 carbon atoms, fluorine resins represented by the formula 4 and 5 and paraffin waxes where m1, m2 and m3 are integers in the range 10-500, n is 1-5, p is 500-1500 and q is 4-7.
Patent NZ-334226-A (NZ)
Title: Humanized immunoglobulin reactive with alpha 4 beta 7 integrin
Inventor: PONATH PAUL D
IPC: C12P21/08
Filed: 1997-08-06
Abstract: The specification describes a humanized immunoglobulin or an antigen-binding fragment which selectively binds a4b7 integrin.  The immunoglobulin or fragment has an antigen binding region of non-human origin and a portion immunoglobulin of human origin.  The antigen-binding region is, preferably, derived from rodents and is an Act-1 monoclonal antibody. The human portion is, preferably, from a human constant region
Patent NZ-500687-A (NZ)
Title: A method and a system for determination of particles using array electromagnetic detectors to build an image which is suited for assessment of somatic cells in a liquid sample
Inventor: HANSEN FRANS EJNER RAVN
IPC: G01N21/64
Filed: 1998-05-05
Abstract: Assessment of the number of cells in a liquid which comprises arranging a volume of a liquid sample representing the analyte material in a sample compartment and allowing electromagnetic signals from the sample in the compartment to pass through and be exposed to the exterior. There is exposed onto an array of active detection elements, an at least one-dimensional spatial representation of electromagnetic signals from the sample. The representation is detectable as intensity, by individual active detection elements. Representations of electromagnetic signs from the cells are identified. The size of the volume of the liquid sample is sufficiently large to permit the assessment of the number of somatic cells to fulfil a predetermined requirement to the statistically quality of the assessment based on substantially one exposure. The preferred embodiment describes the assessment of the number of somatic cells in milk when the purpose is to establish information about the health status of animals, such as cows, sheep or buffaloes, especially in connection with clinical or sub-clinical mastitis.
Patent NZ-508816-A (NZ)
Title: Bactericidal/permeability-increasing protein (BPI) deletion analogs
Inventor: HORWITZ ARNOLD
IPC: C12N15/74
Filed: 1999-06-18
Abstract: Bactericidal/permeability-increasing  protein   (BPI) deletion  analogs are disclosed that consist of  amino  acid residues  10  through 193 of mature human  BPI  wherein  the cysteine  residue at BPI amino acid position 132 is replaced by  another  amino  acid.  Fusion proteins comprising  these analogs  are also disclosed, as are polynucleotides encoding these  products, materials and methods for their recombinant production, compositions and medicaments of these  products, and therapeutic uses for these products.
Patent NZ-520778-A (NZ)
Title: Process for the preparation of phosphorothioate triesters
Inventor: REESE COLIN BERNARD
IPC: C07H21/02
Filed: 2001-02-23
Abstract: A process for the synthesis of a phosphorothioate triester is disclosed, wherein the process comprises the coupling of an H-phosphonate with an alcohol in the presence of a solution comprising both a coupling agent and a sulfur transfer agent. Preferably, the H-phosphonate and alcohol are protected nucleosides or oligonucleotides.
Patent NZ-522722-A (NZ)
Title: Continuous production of pharmaceutical granulation
Inventor: GHEBRE-SELLASSIE ISAAC
IPC: B29C48/285
Filed: 2001-05-14
Abstract: A single pass, continuous, automated system for producing a pharmaceutical granulation includes multiple feeders to feed powders and liquids, a twin screw processor to granulate, a radio frequency or microwave based drying apparatus to dry the granulation, and at least one mill to process the dried granulation to desired particle sizes. The system incorporates means for monitoring key process parameters on-line, all of which are controlled by a controller provided with feedback at each component of the system. The granulation produced can be compressed into a tablet or incorporated into a capsule, both having a uniform distribution of the active ingredient. The system produces product having consistent properties even when production is scaled up for manufacture of the tablet in commercial volume
Patent NZ-523628-A (NZ)
Title: Compounds and methods for treatment and diagnosis of chlamydial infection
Inventor: FLING STEVEN P
IPC: A61K38/00
Filed: 2001-07-20
Abstract: Compounds and methods for the diagnosis and treatment of Chlamydial infection are disclosed. The compounds provided include polypeptides that contain at least one antigenic portion of a Chlamydia antigen and DNA sequences encoding such polypeptides. Pharmaceutical compositions and vaccines comprising such polypeptides or DNA sequences are also provided, together with antibodies directed against such polypeptides. Diagnostic kits containing such polypeptides or DNA sequences and a suitable detection reagent may be used for the detection of Chlamydial infection in patients and in biological samples. In particular, this disclosure relates to the full length serovar D nucleic acid sequence of the gene CT858 and its related protein from Chlamydia trachomatis. These sequences relate to useful antigens, as discussed above.
Patent NZ-527162-A (NZ)
Title: Reading and decoding information from a plurality of forms on packages
Inventor: BONNER BRETT BRACEWELL
IPC: G06V30/10
Filed: 2001-01-18
Abstract: A method of capturing and processing information from a plurality of forms concurrently, comprises: capturing an image of a plurality of forms randomly positioned on a moving conveyor belt (27) and visible to an imager (12), each one of the forms (25) is respectively associated with one of a plurality of packages (25); locating at least one of the plurality of forms in the captured image, at least one of the form comprising a plurality of information data fields; and decoding at least one of the plurality of information data fields.
Patent NZ-528421-A (NZ)
Title: Metallo aluminophosphate molecular sieve with cubic crystal morphology and methanol to olefin process using the sieve
Inventor: BARGER PAUL T
IPC: C01B37/06
Filed: 2001-03-22
Abstract: A catalyst for converting methanol to light olefins and a process for converting methanol to light olefin is disclosed, wherein the catalyst comprising a crystalline metallo aluminophosphate molecular sieve having an empirical chemical composition on an anhydrous basis expressed by the formula (ELxAlyPz)O2 where EL is a metal selected from the group consisting of silicon, magnesium, zinc, iron, cobalt, nickel, manganese, chromium and mixtures thereof, "x" is the mole fraction of EL and has a value of at least 0.005, "y" is the mole fraction of Al and has a value of at least 0.01, "z" is the mole fraction of P and has a value of at least 0.01 and x + y + z = 1, the molecular sieve characterized in that it has predominantly a plate crystal morphology, wherein the average smallest crystal dimension is at least 0.1 micron and has an aspect ratio no greater than 5.
Patent NZ-529323-A (NZ)
Title: The method of wind-collecting power generation and its equipment
Inventor: HUANG CHIENWEN
IPC: F03D3/02
Filed: 2002-04-10
Abstract: A power generating method using accumulated wind power is disclosed. A movable wind-collecting device 10 on a power generation tower 20 is used to guide and accumulate airflow and at least one wind turbine is located on the tower. The wind-collecting device can be moved, rotated or shape-changed, and its inlet transverse section area is greater than the outlet one, so strong airflow can still be generated at the outlet to drive the turbines on the power generation tower under low airflow conditions.
Patent NZ-529567-A (NZ)
Title: Use of triazolopyrimidine derivatives as microbicides in the protection of materials
Inventor: BRUNS RAINER
IPC: C07D487/04
Filed: 2002-05-06
Abstract: The use of triazolopyrimidine derivatives of formula (I), in which R1 represents optionally substituted alkyl, alkenyl, alkynyl, or cycloalkyl, R2 represents hydrogen or alkyl or R1 and R2 together with the nitrogen atom to which they are attached represent an optionally substituted heterocyclic ring, R3 represents optionally substituted aryl, and R4 represents hydrogen or halogen as microbicides for protecting engineered materials, is disclosed. A process for protecting engineered materials against attack and/or destruction by microorganisms, characterized in that at least one compound of formula (I) is allowed to act on the microorganism or its habitat is also described.
Patent NZ-530981-A (NZ)
Title: Formulation containing (lyso-) phosphatidylserine for the prevention and treatment of stress states in warm-blooded animals
Inventor: JAGER RALF
IPC: A61K36/67
Filed: 2002-08-09
Abstract: Use of a formulation containing phosphatidylserine (PS) and/or lyso phosphatidylserine with additional active components is described for the production of an agent for preventing or treating stress states in warm-blooded animals. The stress states are to be associated with an increased secretion of catecholamines. The additional active components are disclosed to be selected from the following, or any mixtures thereof: (a) an active substance of plant origin selected from the group comprising Rhodiola, Ginseng, Schisandra, Suma, camomile, Salix, Ephedra, passion-flower, Gingko, Kava-Kava, St. John's wort, valerian, garlic, Reishi mushrooms; and/or guarana; and/or (b) a compound selected from the group comprising phosphatidyicholine, phosphatidylethanolamine, phosphatidylinositol, taurine, serine, choline, carnithin, phenylalanine, melatonin, tyrosine, theanine, ethanol, creatine citrate, creatine pymvate and/or barbituric acid (derivatives).
Patent NZ-532248-A (NZ)
Title: Titanium-group metal containing high-performance water, and its producing method and apparatus
Inventor: HIRATA YOSHIHIRO
IPC: A61K33/24
Filed: 2002-10-10
Abstract: A method for producing titanium-group metal micro-dispersion water is disclosed, wherein plasma discharge is caused in water between a titanium-group metal electrode and its counter electrode to produce ion vapor of titanium-group metal and cause it to contact, and micro-disperse in, water. Also disclosed is an apparatus for producing titanium-group metal micro-dispersion water, comprising a water tank, a high-voltage discharge generator equipped with a titanium-group metal electrode and its counter electrode, a water inlet, an outlet and a discharge pump for discharging titanium-group metal micro-dispersion water, an electrode vibration/sliding device, and a feeder of the aforementioned titanium-group metal electrode, wherein the ultra-fine dispersion water of a titanium-group metal containing a titanium-group metal ion vapor in an ultra-fine dispersion state is produced by causing a plasma discharge between a titanium-group metal electrode and a counter electrode under water. The ultra-fine dispersion water of a titanium-group metal produced by the above method is suitable for use in health, medical and cosmetic products.
Patent NZ-533252-A (NZ)
Title: Treatment of wounds and compositions employed
Inventor: MONROE STEPHEN H
IPC: A61K33/24
Filed: 2002-11-27
Abstract: Use of a synthesized composition containing pharmaceutically effective amount of a combination of zinc and rubidium ions and optionally potassium ions and/or calcium ions, in a physiologically inert carrier is disclosed. The composition, when applied to an open wound, effectively modulates the activity of at least MMP-2 and/or MMP-9 in the wound.